Home | Welcome to Contract Pharma   
Last Updated Tuesday, March 31 2015

Print

Search Results for 'Financial Report: BASi'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published December 22, 2014
Revenues up 17% in the quarter Read More »
Published August 14, 2014
Service revenues up 14% in the quarter Read More »
By Kristin Brooks
Published February 13, 2014
Revenues up 7% in the quarter driven by Culex sales Read More »
Published December 28, 2012
Restructuring charges impacts results Read More »
Published August 14, 2012
Restructuring charges impact results Read More »
Published February 10, 2012
Revenues drop 7% Read More »
Published February 8, 2011
Results reflect higher revenues in both the service and product segments, as well as $265,000 of reduced operating expenses. Read More »
Published December 29, 2010
Revenues down, but improving in 2H10 Read More »
Published August 9, 2007
BASi 3Q Revenues: $12.6 million (26%) 3Q Earnings: $449,000 (loss of $1.8 million 3Q2006) YTD Revenues: $34.8 million (+8%) YTD Earnings: $1.1 million (loss of $1.9 million YTD2006) Comments: Revenue growth was driven by a $2.7… Read More »
Published February 27, 2012
Identification of a biological, genetic or protein target linked to a particular disease, and subsequent lead identification of a potential drug that interacts with the target to help cure the disease or halt its progression.… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On